Why hasn't Trump fired J Powell..he is the one who keeps taking our gains with flip flopping around about interest rate cuts ..what's the time wasting on anticipating fomc rate cuts only for him to yapp around and destroy portfolios with his goal post moving tactics..we need someone who can make a decision..it's either you are cutting rates or not..

---

Shit Scott That aki-mofo be messing with my lady gotta be running cold upsidedown his head you know what I'm sayin mans? Hey holmes I can dig it that brotha ain't gonna pick up on you man i say hey Scott, So to say i want to say pretty J I did the same-ol same-ol hey knock yourself on a post lick the gray metal fat man before he was down I take tcb'in man Hey you know what they say you see about to get that boottie yacker you lay her down and slackum yackum cold gotta be ya know man SHIT

---

**Ban Bet Created:** **/u/J-E-S-S-E-** bet **TTD** goes from **50.55** to **63.0** before **07-Nov-2025 11:08 AM EDT** Their record is 1 wins and 3 losses. [**Join WSB Discord**](https://discord.gg/wsbverse) | [**⚔**](https://www.reddit.com/r/KarmaCave/)

---

KVUE was spun off j&j for a reason.. no growth, high debt, high dividend. Pass

---

Super manipulated by GS, who do work for NVO and LLY and want to protect them. Fuck them. The data are better, 25% SI, and p3-ready in MASH and obesity - right when FDA is making it easier. I hope they get burned hard. There are bidding wars for MASH/obesity drugs right now...they should know better.

---

$ALT is being manipulated by GS to protect NVO and LLY...but data are better. 25% SI. This could run hard when buyout rumors start, bidding wars in MASH/obesity drugs and a paucity of p3-ready options.

---

100% being shorted by GS to protect NVO and LLY. Data are better and heavily shorted.

---

$ALT looks primed for a breakout soon.  Late Breaking data & oral presentation @ AASLD nov 8-11.  Obesity phase 3 ready. MASH resolution & fibrosis improvement best in class at 24 weeks once FDA accepts NITs any day.   Renewed bidding wars between pfizer and Novo for a phase 1 obesity asset the same day Lilly announces their glp1 is the best selling drug in the world.   GS has been suppressing this SP indiscriminately to protect the market for their customers NOVO & LILly.  A huge risk reward value only days away from business updates  AND key oral presentation at THE liver conference of the year.  Now is the time to load up!  This drug pemvutide is next generation.  Better quality weight loss than good diet and we exercise(21% lean muscle loss vs 24% good diet & Exercise), great tolerability due to proprietary euport technology, 74 % liver fat reduction.  6% weight loss at 24 weeks. Its a healthy new liver for all drinkers with a side of weight loss.  

---

Currently holding $1M+, 60,000 shares of RKT... [https://www.reddit.com/r/wallstreetbets/comments/1oj76qk/rkt\_60k\_shares1m\_earnings\_tomorrow\_rkt\_price/](https://www.reddit.com/r/wallstreetbets/comments/1oj76qk/rkt_60k_shares1m_earnings_tomorrow_rkt_price/) BTIG and BoA have $25 targets for it, for '26. GS has $22, by '26.

---

Other than J Pow having diarrhea at the mouth did I miss some bad news? Why is everything drilling?

---